9 studies found for:    16702586 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Condition: Cirrhosis
Intervention:
2 Terminated Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis;   HIV/AIDS
Interventions: Drug: Boceprevir;   Drug: Peg-Interferon-alfa 2B;   Drug: Ribavirin
3 Recruiting Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV
Condition: HIV-HCV
Intervention: Drug: Asunaprevir and Dalatasvir
4 Completed High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon;   Drug: Ribavirin
5 Completed
Has Results
S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: S-adenosyl methionine for Chronic Liver Disease
6 Active, not recruiting GS-7977 Alone or With Ribavirin for Hepatitis C
Condition: Hepatitis C
Interventions: Drug: GS7977;   Drug: RBV
7 Recruiting Combination Therapy for Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Fixed Dose GS-7977/GS-5885;   Drug: FDC with GS-9451;   Drug: FDC with GS-9669
8 Active, not recruiting Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
Conditions: Hepatitis C;   HIV
Intervention: Drug: GS-7977/GS- 5885 FDC
9 Not yet recruiting Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
Condition: Chronic Hepatitis C Virus Infection
Intervention:

Indicates status has not been verified in more than two years